The best phase I deal i know of at least off hand was Plexxikon/Roche and it was actually at pre IND stage. Biobucks should turn into real bucks, Roche paid all the development costs plus a 20%+ royalty.
Bristol is so Bristol shelling out so much money for lambda. I don't get it.
Market Data 
Markets 
AI
